Original language | English (US) |
---|---|
Article number | 115446 |
Journal | Diagnostic Microbiology and Infectious Disease |
Volume | 101 |
Issue number | 2 |
DOIs | |
State | Published - Oct 2021 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Comparison of the clinical practice guidelines for Lyme disease from the Infectious Diseases Society of America : 2000, 2006, and 2020. / Wormser, Gary P.; Strle, Franc; Shapiro, Eugene D. et al.
In: Diagnostic Microbiology and Infectious Disease, Vol. 101, No. 2, 115446, 10.2021.Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Comparison of the clinical practice guidelines for Lyme disease from the Infectious Diseases Society of America
T2 - 2000, 2006, and 2020
AU - Wormser, Gary P.
AU - Strle, Franc
AU - Shapiro, Eugene D.
AU - Auwaerter, Paul G.
N1 - Funding Information: Dr Wormser reports receiving research grants from the Institute for Systems Biology and Pfizer, Inc. He owns equity in Abbott/AbbVie; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the nonprofit American Lyme Disease Foundation. Dr Strle served on the scientific advisory board for Roche on Lyme disease serological diagnostics and on the scientific advisory board for Pfizer on Lyme disease vaccine, received research support from the Slovenian Research Agency [grant numbers: P3-0296, J3-1744, and J3-8195], and is an unpaid member of the steering committee of the ESCMID Study Group on Lyme Borreliosis/ESGBOR. Dr Shapiro receives royalties for UptoDate; has been an expert witness in malpractice cases involving Lyme disease; has consulted for Pfizer; and is an unpaid board member of the nonprofit American Lyme Disease Foundation. Dr Auwaerter has consulted for DiaSorin, Adaptive Biotherapeutics, and Pfizer; has done research sponsored by MicroB-Plex; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the American Lyme Disease Foundation. Funding Information: Dr Wormser reports receiving research grants from the Institute for Systems Biology and Pfizer, Inc . He owns equity in Abbott/AbbVie; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the nonprofit American Lyme Disease Foundation. Dr Strle served on the scientific advisory board for Roche on Lyme disease serological diagnostics and on the scientific advisory board for Pfizer on Lyme disease vaccine, received research support from the Slovenian Research Agency [grant numbers: P3-0296 , J3-1744 , and J3-8195 ], and is an unpaid member of the steering committee of the ESCMID Study Group on Lyme Borreliosis/ESGBOR. Dr Shapiro receives royalties for UptoDate; has been an expert witness in malpractice cases involving Lyme disease; has consulted for Pfizer; and is an unpaid board member of the nonprofit American Lyme Disease Foundation. Dr Auwaerter has consulted for DiaSorin, Adaptive Biotherapeutics, and Pfizer; has done research sponsored by MicroB-Plex; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the American Lyme Disease Foundation.
PY - 2021/10
Y1 - 2021/10
UR - http://www.scopus.com/inward/record.url?scp=85109675040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109675040&partnerID=8YFLogxK
U2 - 10.1016/j.diagmicrobio.2021.115446
DO - 10.1016/j.diagmicrobio.2021.115446
M3 - Editorial
C2 - 34256207
AN - SCOPUS:85109675040
SN - 0732-8893
VL - 101
JO - Diagnostic Microbiology and Infectious Disease
JF - Diagnostic Microbiology and Infectious Disease
IS - 2
M1 - 115446
ER -